Role of plasminogen activator inhibitor-1 in glucocorticoid-induced muscle change in mice.
Role of plasminogen activator inhibitor-1 in glucocorticoid-induced muscle change in mice.
复制标题
纤溶酶原激活剂抑制剂-1 在糖皮质激素诱导的小鼠肌肉变化中的作用。
DOI:
10.1007/s00774-017-0825-8
复制
发表时间:
2017
影响因子:
3.3
通讯作者:
Kaji H.
中科院分区:
文献类型:
--
作者:
Tamura Y;Kawao N;Shimoide T;Okada K;Matsuo O;Kaji H.
We recently revealed that plasminogen activator inhibitor-1 (PAI-1), a serine protease inhibitor, is involved in diabetes, osteoporosis and muscle wasting induced by glucocorticoid (GC) treatment in mice. In the present study, we investigated the detailed mechanisms by which GC induces muscle wasting through PAI-1 in vivo and in vitro. PAI-1 deficiency suppressed the mRNA levels ofatrogin1andmuscle RING-Finger Protein 1(MuRF1), ubiquitin ligases leading to muscle degradation, elevated by GC treatment in the gastrocnemius muscle of mice. In vitro study revealed that active PAI-1 treatment augmented the increase inatrogin1mRNA levels enhanced by dexamethasone (Dex) in mouse myoblastic C2C12 cells. Moreover, a reduction in endogenous PAI-1 level by siRNA suppressed the mRNA levels ofatrogin1andMuRF1enhanced by Dex in C2C12 cells. In contrast, a reduction in endogenous PAI-1 levels and active PAI-1 did not affect the phosphorylations of Akt and p70S6 kinase nor myogenic differentiation with or without Dex in C2C12 cells. In addition, PAI-1 deficiency bluntedIGF-1 mRNA levelsdecreased by GC treatment in the gastrocnemius muscle of mice, although neither active PAI-1 nor a reduction in endogenous PAI-1 levels affected the levels ofIGF-1mRNA in C2C12 cells in the presence of Dex. In conclusion, our data suggest that paracrine PAI-1 is involved in GC-induced muscle wasting through the enhancement of muscle degradation in mice.